238120.KQ Aligned Genetics Inc

Healthcare Oil, Gas & Consumable Fuels KOSDAQ
2,570 KRW
Close of Oct 31, 2026
2,345 6,050
Market cap
KRW 36.4B
P/E
7.6x
P/B
0.93x
ROE
11.1%
Dividend yield
-
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 238120.KQ undervalued?

Graham number
Price2,570
Graham value4,596
Discount44.1%

238120.KQ trades 44.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aligned Genetics Inc fundamental analysis

13 of 22 checks passed

ROE 1/2

Moderate return on equity (11.1%), between 10% and 20%.

ROA 1/1

Return on assets (7.2%) is above the industry median (1.4%).

Profit Consistency 2/2

Profitable for 7 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-27.9%) is not above the 5-year average (26.0% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-27.9%) is below the industry median (1.8%).

Revenue Growth 1/2

Revenue grew 5.2% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (30.1%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 10.1x against interest expense, well covered.

PE vs Market 1/1

PE (7.6x) is below the market median (11.3x).

PE vs Industry 1/1

PE (7.6x) is below the industry median (11.4x).

PBV 0/1

Price to book (0.9x) is above the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 7.0, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.29, growth is cheap.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Aligned Genetics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aligned Genetics Inc

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.

Full company profile